{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:18:13Z","timestamp":1793924293567,"version":"4.8.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:p>\n                    This study investigates the relationship between serum nesfatin-1 level and clinical parameters such as pain intensity, disease activity, anxiety, depression, sleep quality, and quality of life in patients with fibromyalgia syndrome (FMS). Eighty-two FMS cases and 82 control patients, aged between 18 to 65, were included in this cross-sectional study. The Visual Analog Scale, Fibromyalgia Impact Questionnaire, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Pittsburgh Sleep Quality Index, and Short Form-36 were used to analyze the patients. Nesfatin-1 levels were determined using an enzyme-linked immunosorbent assay. The Visual Analog Scale, BDI, BAI, Pittsburgh Sleep Quality Index, and Fibromyalgia Impact Questionnaire scores were significantly higher in patients with FMS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The quality of life scores of the patients with FMS were significantly lower (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Serum nesfatin-1 concentration was significantly lower in patients with FMS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). A significant positive correlation (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) was detected between nesfatin-1 and BAI and BDI scores in the FMS patient group, and a significant negative correlation (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) was found between nesfatin-1 and body mass index. Low plasma nesfatin-1 levels may contribute to the pathological changes in FMS. Additionally, nesfatin-1 may be involved in mediating anxiety and depression-related responses in FMS patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043512","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:10:48Z","timestamp":1757355048000},"page":"e43512","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of plasma nesfatin-1 level on clinical and quality of life in patients with fibromyalgia syndrome"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5455","authenticated-orcid":false,"given":"Muhammet Sahin","family":"Elbasti","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Health Sciences University, Fethi Sekin City Hospital, Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Gulkesen","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Firat University, Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Alkan","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Firat University, Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Akgol","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Firat University, Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Firat University, Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Kaman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Firat University, Elazig, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20251029","first-page":"e44852","article-title":"Is fibromyalgia a fashionable diagnosis or a medical mystery?","volume":"15","author":"Varrassi","year":"2023","journal-title":"Cureus"},{"key":"R3-20251029","first-page":"1205","article-title":"Fibromyalgia: one year in review 2023.","volume":"41","author":"Giorgi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1093\/rheumatology\/kead136","article-title":"Fibromyalgia remains the elephant in the clinic room.","volume":"62","author":"Tran","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11064-023-04037-0","article-title":"Nesfatin-1: a biomarker and potential therapeutic target in neurological disorders.","volume":"49","author":"Zhou","year":"2024","journal-title":"Neurochem Res"},{"key":"R6-20251029","doi-asserted-by":"crossref","first-page":"171043","DOI":"10.1016\/j.peptides.2023.171043","article-title":"Role of brain NUCB2\/nesfatin-1 in stress and stress-related gastrointestinal disorders.","volume":"167","author":"Zheng","year":"2023","journal-title":"Peptides"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.46497\/ArchRheumatol.2021.7736","article-title":"Is there any association between low level of serum nesfatin-1 and fibromyalgia syndrome?","volume":"36","author":"Bilgici","year":"2020","journal-title":"Arch Rheumatol"},{"key":"R8-20251029","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","article-title":"Measurement of pain.","volume":"2","author":"Huskisson","year":"1974","journal-title":"Lancet"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3346\/jkms.2018.33.e128","article-title":"Exploratory factor analysis of the beck anxiety inventory and the beck depression inventory-II in a psychiatric outpatient population.","volume":"33","author":"Lee","year":"2018","journal-title":"J Korean Med Sci"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"R11-20251029","first-page":"163","article-title":"The Beck Anxiety Inventory: psychometric properties.","volume":"12","author":"Ulusoy","year":"1998","journal-title":"J Cogn Psychother"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/occmed\/kqv087","article-title":"Beck depression inventory.","volume":"66","author":"Jackson-Koku","year":"2016","journal-title":"Occup Med (Lond)"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"R14-20251029","first-page":"118","article-title":"The reliability and validity study of Beck Depression Inventory in a Turkish sample.","volume":"6","author":"Hisli","year":"1988","journal-title":"Turkish J Psychol"},{"key":"R15-20251029","first-page":"728","article-title":"The fibromyalgia impact questionnaire: developed and validation.","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002960000077","article-title":"The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire.","volume":"20","author":"Sarmer","year":"2000","journal-title":"Rheumatol Int"},{"key":"R17-20251029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","article-title":"The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis.","volume":"25","author":"Mollayeva","year":"2016","journal-title":"Sleep Med Rev"},{"key":"R18-20251029","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"R19-20251029","first-page":"107","article-title":"Pittsburgh Uyku Kalitesi Indeksi\u2019nin ge\u00e7erlili\u011fi ve g\u00fcvenirli\u011fi.","volume":"7","author":"A\u011farg\u00fcn","year":"1996","journal-title":"Turk Psikiyatri Derg"},{"key":"R20-20251029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R21-20251029","first-page":"102","article-title":"Kisa Form-36 (KF-36)\u2019nin T\u00fcrk\u00e7e versiyonunun g\u00fcvenilirli\u011fi ve ge\u00e7erlili\u011fi.","volume":"12","author":"Ko\u00e7yi\u011fit","year":"1999","journal-title":"\u0130la\u00e7 ve Tedavi Dergisi"},{"key":"R22-20251029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/postgradmedj-2021-140336","article-title":"Can fibromyalgia be considered a characteristic symptom of climacterium?","volume":"99","author":"Ozcivit","year":"2023","journal-title":"Postgrad Med J"},{"key":"R23-20251029","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/nu11051193","article-title":"The Association of Body Mass Index and body composition with pain, disease activity, fatigue, sleep and anxiety in women with fibromyalgia.","volume":"11","author":"Correa-Rodr\u00edguez","year":"2019","journal-title":"Nutrients"},{"key":"R24-20251029","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2021.02.007","article-title":"Fibromyalgia and obesity: a comprehensive systematic review and meta-analysis.","volume":"51","author":"D\u2019Onghia","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R25-20251029","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.dsx.2014.04.010","article-title":"Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects.","volume":"9","author":"Mirzaei","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"R26-20251029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.peptides.2016.09.014","article-title":"Association between nesfatin-1 levels and metabolic improvements in severely obese patients who underwent biliopancreatic derivation with duodenal switch.","volume":"86","author":"St-Pierre","year":"2016","journal-title":"Peptides"},{"key":"R27-20251029","doi-asserted-by":"crossref","first-page":"E669","DOI":"10.1210\/jc.2010-1782","article-title":"Decreased cerebrospinal fluid\/plasma ratio of the novel satiety molecule, nesfatin-1\/NUCB-2, in obese humans: evidence of nesfatin-1\/NUCB-2 resistance and implications for obesity treatment.","volume":"96","author":"Tan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20251029","first-page":"189","article-title":"The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.","volume":"14","author":"Abaci","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"R29-20251029","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.peptides.2010.10.004","article-title":"Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa.","volume":"32","author":"Ogiso","year":"2011","journal-title":"Peptides"},{"key":"R30-20251029","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.brs.2017.06.006","article-title":"Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: A double blinded, randomized clinical trial.","volume":"10","author":"Khedr","year":"2017","journal-title":"Brain Stimul"},{"key":"R31-20251029","doi-asserted-by":"crossref","first-page":"v35i1a14781","DOI":"10.17159\/2078-516X\/2023\/v35i1a14781","article-title":"Physical activity and quality of life of patients with fibromyalgia.","volume":"35","author":"Smith","year":"2023","journal-title":"S Afr J Sports Med"},{"key":"R32-20251029","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1111\/jsm.12651","article-title":"Prevalence and risk factors of sexual problems and sexual distress in a sample of women suffering from chronic widespread pain.","volume":"11","author":"Burri","year":"2014","journal-title":"J Sex Med"},{"key":"R33-20251029","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2147\/NDT.S138954","article-title":"High levels of nesfatin-1 in relation to the dysfunction of the hypothalamic\u2013pituitary\u2013adrenal and hypothalamus\u2013pituitary\u2013thyroid axes in depressed patients with subclinical hypothyroidism.","volume":"13","author":"Xu","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R34-20251029","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1590\/0004-282x20160141","article-title":"Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters.","volume":"74","author":"Alves","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"R35-20251029","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/1756-185X.12603","article-title":"The impact of depressive and bipolar symptoms on socioeconomic status, core symptoms, function and severity of fibromyalgia.","volume":"20","author":"Gota","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R36-20251029","doi-asserted-by":"crossref","first-page":"1120250","DOI":"10.3389\/fpsyt.2023.1120250","article-title":"Psychiatric disorders and the onset of self-reported fibromyalgia and chronic fatigue syndrome: the lifelines cohort study.","volume":"14","author":"Creed","year":"2023","journal-title":"Front Psychiatry"},{"key":"R37-20251029","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.npep.2011.12.002","article-title":"Nesfatin-1, a unique regulatory neuropeptide of the brain.","volume":"46","author":"Pa\u0142asz","year":"2012","journal-title":"Neuropeptides"},{"key":"R38-20251029","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/biomedicines12081913","article-title":"Nesfatin-1: a novel diagnostic and prognostic biomarker in digestive diseases.","volume":"12","author":"Damian-Buda","year":"2024","journal-title":"Biomedicines"},{"key":"R39-20251029","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/biomedicines12061265","article-title":"Correlation of psychological factors, obesity, serum cortisol, and C-reactive protein in patients with fibromyalgia diagnosed with obstructive sleep apnea and other comorbidities.","volume":"12","author":"Meresh","year":"2024","journal-title":"Biomedicines"},{"key":"R40-20251029","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2017.09.024","article-title":"NUCB2\/nesfatin-1: expression and functions in the regulation of emotion and stress.","volume":"81","author":"Wei","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R41-20251029","doi-asserted-by":"crossref","first-page":"15288","DOI":"10.1038\/s41598-023-42513-3","article-title":"High plasma nesfatin-1 level in Chinese adolescents with depression.","volume":"13","author":"Sun","year":"2023","journal-title":"Sci Rep"},{"key":"R42-20251029","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12888-018-1672-4","article-title":"Plasma nesfatin-1 level is associated with severity of depression in Chinese depressive patients.","volume":"18","author":"Xiao","year":"2018","journal-title":"BMC Psychiatry"},{"key":"R43-20251029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psyneuen.2018.09.037","article-title":"Role of nesfatin-1 in anxiety, depression and the response to stress.","volume":"100","author":"Weibert","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"R44-20251029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5455\/bcp.20130421014608","article-title":"Is There any association between nesfatin-1 and generalized anxiety disorder.","volume":"24","author":"Bahceci","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bulletin Clin Psychopharmacol"},{"key":"R45-20251029","first-page":"S140","article-title":"Transdiagnostic factors across fibromyalgia and mental disorders: sleep disturbances may play a key role. A clinical review.","volume":"34","author":"Palagini","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R46-20251029","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JOE-16-0361","article-title":"Nesfatin-1: functions and physiology of a novel regulatory peptide.","volume":"232","author":"Dore","year":"2017","journal-title":"J Endocrinol"},{"issue":"4","key":"R47-20251029","doi-asserted-by":"crossref","first-page":"e59809","DOI":"10.1371\/journal.pone.0059809","article-title":"Nesfatin-1\/NUCB2 as a Potential New Element of Sleep Regulation in Rats.","volume":"8","author":"Vas","year":"2013","journal-title":"PLoS ONE"},{"key":"R48-20251029","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/biomedicines11041119","article-title":"A comprehensive review of the genetic and epigenetic contributions to the development of fibromyalgia.","volume":"11","author":"Ovrom","year":"2023","journal-title":"Biomedicines"},{"key":"R49-20251029","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10880-021-09794-0","article-title":"The effect of psychological interventions on the quality of life in women with fibromyalgia: a systematic review.","volume":"28","author":"Samami","year":"2021","journal-title":"J Clin Psychol Med Settings"},{"key":"R50-20251029","first-page":"4506","article-title":"Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses.","volume":"25","author":"Celepkolu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:04:45Z","timestamp":1761750285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":49,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043512","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"2024-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}